Gentian Diagnostics ASA
Develops and markets in vitro diagnostic reagents for human and veterinary use.
GENT | OL
Overview
Corporate Details
- ISIN(s):
- NO0010748866
- LEI:
- 5967007LIEEXZXHNM861
- Country:
- Norway
- Address:
- Bjørnåsveien 5, 1596 Moss
- Website:
- https://www.gentian.com/
- Sector:
- Manufacturing
Description
Gentian Diagnostics ASA is a medical diagnostics company that develops, manufactures, and markets innovative in vitro diagnostic (IVD) reagents. The company specializes in turbidimetric immunoassays designed for open clinical chemistry platforms, aiming to enhance laboratory efficiency and support better clinical treatment decisions. Its portfolio and pipeline of diagnostic tests address biomarkers in high-impact medical areas, including kidney disease, cardiac disease, inflammation, and infection. Key products include assays for Cystatin C, NGAL, and Calprotectin. In addition to its human diagnostics portfolio, the company provides diagnostic solutions for the veterinary market. Gentian serves a global customer base through original equipment manufacturer (OEM) partners, distributors, and healthcare providers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-06-23 08:53 |
Oslo Børs – Resolution of transfer of listing from Euronext Growth to Oslo Børs…
|
English | 737 bytes | ||
| 2021-06-18 05:30 |
Gentian Diagnostics: Invitation to virtual presentation at 24 June
|
English | 1.6 KB | ||
| 2021-06-18 05:15 |
Gentian Diagnostics: A long-term revenue ambition of NOK 1 billion from a portf…
|
English | 3.0 MB | ||
| 2021-06-18 05:15 |
Gentian Diagnostics: A long-term revenue ambition of NOK 1 billion from a portf…
|
English | 4.6 KB | ||
| 2021-05-07 12:22 |
Application for transfer of shares admitted to trading on Euronext Growth to to…
|
English | 490 bytes | ||
| 2021-05-07 11:57 |
Gentian Diagnostics ASA – Application for admission to trading on Oslo Børs
|
English | 1.1 KB | ||
| 2021-05-07 08:28 |
Gentian Diagnostics ASA – conversion to public limited liability company regist…
|
English | 1.1 KB | ||
| 2021-05-04 18:18 |
Minutes of Annual General Meeting
|
English | 7.5 MB | ||
| 2021-05-04 18:18 |
Minutes of Annual General Meeting
|
English | 660 bytes | ||
| 2021-04-29 20:14 |
2021 Annual general meeting - proposal from the nomination committee
|
English | 535 bytes | ||
| 2021-04-22 06:33 |
Notice of Annual General Meeting
|
English | 519.3 KB | ||
| 2021-04-22 06:33 |
Notice of Annual General Meeting
|
English | 1.1 KB | ||
| 2021-04-16 10:37 |
Annual report 2020
|
English | 3.3 MB | ||
| 2021-04-16 10:37 |
Annual report 2020
|
English | 771 bytes | ||
| 2021-04-16 06:15 |
First quarter 2021 report
|
English | 515.4 KB |
Automate Your Workflow. Get a real-time feed of all Gentian Diagnostics ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Gentian Diagnostics ASA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Gentian Diagnostics ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
